Table 5.
Laboratory Data in Patients with CS.
# CS studies | Mean value (SD) | # control studies | Mean value | p-value | |
---|---|---|---|---|---|
PROTHROMBOTIC FACTORS | |||||
vWF (IU/dL) | 16 | 180.03 (64.20) | 10 | 112.53 (20.06) | 0.004 |
PAI-1 (IU/mL) | 13 | 22.99 (23.94) | 10 | 23.35 (29.65) | 0.9750 |
Prothrombin time | 10 | 104.49 (6.78) | 5 | 94.49 (6.79) | 0.02 |
aPTT (sec) | 19 | 26.91 (2.28) | 12 | 30.65 (2.95) | 0.0004 |
Fibrinogen (mg/dL) | 16 | 367.85 (63.90) | 12 | 310.43 (69.04) | 0.03 |
Homocysteine (μmol/L) | 2 | 15.0 (3.96) | 2 | 11.4 (1.27) | 0.35 |
AT-III (%) | 12 | 109.26 (26.09) | 8 | 88.98 (28.45) | 0.12 |
Factor-VIII (IU/dL) | 14 | 168.94 (23.92) | 10 | 123.42 (72.43) | 0.04 |
ANTITHROMBOTIC FACTORS | |||||
Protein-S Ag | 11 | 112.25 (20.89) | 7 | 85.74 (17.65) | 0.01 |
Protein-C Ag | 12 | 142.18 (8.59) | 8 | 108.74 (13.69) | < 0.0000 |